Intrapulmonary Pharmacokinetics of First-line Anti-tuberculosis Drugs in Malawian Patients With Tuberculosis

BACKGROUND: Further work is required to understand the intrapulmonary pharmacokinetics of first-line anti-tuberculosis drugs. This study aimed to describe the plasma and intrapulmonary pharmacokinetics of rifampicin, isoniazid, pyrazinamide, and ethambutol, and explore relationships with clinical tr...

Descripción completa

Detalles Bibliográficos
Autores principales: McCallum, Andrew D, Pertinez, Henry E, Else, Laura J, Dilly-Penchala, Sujan, Chirambo, Aaron P, Sheha, Irene, Chasweka, Madalitso, Chitani, Alex, Malamba, Rose D, Meghji, Jamilah Z, Gordon, Stephen B, Davies, Geraint R, Khoo, Saye H, Sloan, Derek J, Mwandumba, Henry C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Online only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563277/
https://www.ncbi.nlm.nih.gov/pubmed/32856694
http://dx.doi.org/10.1093/cid/ciaa1265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563277/
https://www.ncbi.nlm.nih.gov/pubmed/32856694
http://dx.doi.org/10.1093/cid/ciaa1265

Ejemplares similares